ACS Central Science · 2016 · 105 citations · 72 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationHit-to-lead OptimizationLead Compound DesignLead DiscoveryLigand-based DesignAntimalarial AgentsAntimalarial Drug DevelopmentLow SolubilityMalaria EliminationMedicinal Chemistry ApplicationsSensitivitySolubilityTreatment Of Malaria
The development of new antimalarial compounds remains a pivotal part of the strategy for malaria elimination. Recent large-scale phenotypic screens have provided a wealth of potential starting points for hit-to-lead campaigns. One such public set is explored, employing an open source research mechanism in which all data and ideas were shared in real time, anyone was able to participate, and patents were not sought. One chemical subseries was found to exhibit oral activity but contained a labile ester that could not be replaced without loss of activity, and the original hit exhibited remarkable sensitivity to minor structural change. A second subseries displayed high potency, including activity within gametocyte and liver stage assays, but at the cost of low solubility. As an open source research project, unexplored avenues are clearly identified and may be explored further by the community; new findings may be cumulatively added to the present work.
72
Artemisinin Resistance in <i>Plasmodium falciparum</i> Malaria
Arjen M. Dondorp, François Nosten, Poravuth Yi et al. · New England Journal of Medicine · 2009 · 3.5K citations · Full text
Thousands of chemical starting points for antimalarial lead identification
Francisco‐Javier Gamo, Laura M. Sanz, Jaume Vidal et al. · Nature · 2010 · 1K citations